Bank Pictet & Cie (Asia)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bank Pictet & Cie (Asia)'s LLY Position: Q2 2024 in Review
Bank Pictet & Cie (Asia) increased its Eli Lilly (LLY) stake by 1.2% in Q2 2024, buying an estimated $13.6K and bringing the position to 1,439 shares worth $1.3M. The position accounts for 0.08% of the portfolio, ranked #40.
Bank Pictet & Cie (Asia) first reported a position in LLY in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.92M in Q4 2023. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.
- Bank Pictet & Cie (Asia) held 1,439 shares of Eli Lilly worth $1.3M as of Q2 2024.
- Bank Pictet & Cie (Asia) bought 17 Eli Lilly shares in Q2 2024, an estimated $13.6K.
- Eli Lilly made up 0.08% of Bank Pictet & Cie (Asia)'s portfolio in Q2 2024, its #40 holding.
- Bank Pictet & Cie (Asia) first reported a position in Eli Lilly in Q2 2021 and has held it in 13 quarters since.
- Bank Pictet & Cie (Asia)'s Eli Lilly position peaked at $1.92M in Q4 2023.
- 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.
Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2024, filed 16 Jul 2024.